GB0909198D0 - Methods and composition for treating NF-kappa B mediated disorders - Google Patents
Methods and composition for treating NF-kappa B mediated disordersInfo
- Publication number
- GB0909198D0 GB0909198D0 GBGB0909198.4A GB0909198A GB0909198D0 GB 0909198 D0 GB0909198 D0 GB 0909198D0 GB 0909198 A GB0909198 A GB 0909198A GB 0909198 D0 GB0909198 D0 GB 0909198D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- kappa
- treating
- composition
- methods
- mediated disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0909198.4A GB0909198D0 (en) | 2009-05-28 | 2009-05-28 | Methods and composition for treating NF-kappa B mediated disorders |
PCT/GB2010/001054 WO2010136766A2 (en) | 2009-05-28 | 2010-05-28 | Methods and compositions for treating nf-kappa b mediated disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0909198.4A GB0909198D0 (en) | 2009-05-28 | 2009-05-28 | Methods and composition for treating NF-kappa B mediated disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0909198D0 true GB0909198D0 (en) | 2009-07-15 |
Family
ID=40902246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0909198.4A Ceased GB0909198D0 (en) | 2009-05-28 | 2009-05-28 | Methods and composition for treating NF-kappa B mediated disorders |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0909198D0 (en) |
WO (1) | WO2010136766A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115161289B (en) * | 2022-03-14 | 2023-12-05 | 东南大学 | Recombinant adeno-associated virus for treating inflammatory diseases, construction method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ547156A (en) * | 2003-10-31 | 2009-08-28 | Univ British Columbia | Attenuation of A/E pathogen virulence by modulating expression of NleA |
WO2011007350A2 (en) * | 2009-07-13 | 2011-01-20 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Immunomodulatory agents and a tissue-targeted delivery system thereof for the treatment of immune-related disorders |
-
2009
- 2009-05-28 GB GBGB0909198.4A patent/GB0909198D0/en not_active Ceased
-
2010
- 2010-05-28 WO PCT/GB2010/001054 patent/WO2010136766A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010136766A2 (en) | 2010-12-02 |
WO2010136766A3 (en) | 2011-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20182135T1 (en) | Compositions and methods for treating ige-mediated disorders | |
EP2170309A4 (en) | Methods and compositions for treating disorders | |
HK1174064A1 (en) | Methods and compositions for cell-proliferation-related disorders | |
EP2406389A4 (en) | Methods and compositions for cell-proliferation-related disorders | |
IL213526A0 (en) | Methods for treating acute myocardial infarctions and associated disorders | |
IL209032A0 (en) | Compositions and methods for treating digestive disorders | |
PL2894165T3 (en) | Methods and compositions for treating complement-associated disorders | |
EP2461819A4 (en) | Methods and compositions for treating trinucleotide repeat disorders | |
EP2331088A4 (en) | Compositions and methods for treating psychiatric disorders | |
EP2396019A4 (en) | Method and compositions for treating skin | |
EP2429530A4 (en) | Methods and compositions for treating degenerative and ischemic disorders | |
HK1206590A1 (en) | New compositions for treating cmt and related disorders | |
EP2497482A4 (en) | Composition for preventing and treating influenza-virus-induced diseases | |
EP2309858A4 (en) | Compositions and methods for treating inflammatory disorders | |
EP2504428A4 (en) | Methods and compositions for treating oxalate-related conditions | |
IL210097A0 (en) | Compositions and methods for treating unfluenza | |
EP2429584A4 (en) | Methods and compositions for treatment | |
ZA201203002B (en) | Compositions and methods for treating inflammatory disorders | |
EP2355657A4 (en) | Compositions and methods of treating endothelial disorders | |
IL215932A0 (en) | Compositions and methods for treating burns | |
EP2485738A4 (en) | Compositions and methods for treating obesity | |
EP2431041A4 (en) | Pharmaceutical composition for treating cardiovascular disorder and use thereof | |
EP2237777A4 (en) | Compositions and methods for treating neurodegenerative diseases | |
EP2512504A4 (en) | Treatment composition and method | |
EP2393506A4 (en) | Methods and compositions for treating neuropathies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |